Wipro GE Healthcare has announced that it will invest over Rs 8,000 crore in India over the next five years to increase local manufacturing and research and development (R&D).

The company, a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider, said as a part of the investment, its 'Made in India' PET CT Discovery IQ scanner will be exported to 15 countries.

Additionally, locally produced Revolution Aspire CT, Revolution ACT and MR breast coils will be manufactured 'In India for the World', the company said in a statement.

The strategic investment bolsters the company's local manufacturing footprint to address the growing domestic and international market. It will also build supply chain resiliency for the organisation, it added.

Wipro GE Healthcare Chairman Azim Premji said India is riding the resurgent growth in the healthcare industry and rapidly expanding MedTech sector.

"With 'Make in India', we are witnessing an exponential expansion of manufacturing footprint in the country, strengthening India's capability as the MedTech hub of the world.

"Wipro GE Healthcare has been committed to this localisation journey for over three decades and this strategic investment is testament to our vision for this sector," added Premji, who is also the Chairman of Wipro Enterprises and the Azim Premji Foundation.